PTCT – ptc therapeutics, inc. (US:NASDAQ)
Stock Stats
News
5/2
08:00 am
ptct
Low
PTC Therapeutics to Participate at Upcoming Investor Conferences
4/29
08:03 am
ptct
High
PTC Therapeutics, Inc. (NASDAQ: PTCT) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $30.00 price target on the stock, up previously from $28.00.
4/28
09:44 am
ptct
High
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts [Yahoo! Finance]
4/27
09:43 am
ptct
High
PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
4/25
09:52 pm
ptct
High
Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics [Yahoo! Finance]
4/25/2024
04:05 pm
ptct
12.1%
BEAT
2/29/2024
04:05 pm
ptct
13.3%
MISS
10/26/2023
04:05 pm
ptct
-22.7%
MISS
8/3/2023
04:01 pm
ptct
-4.0%
MISS
4/29
08:03 am
Upgrades
Underweight
Equal Weight
Morgan Stanley
High
12.2%
4/29
08:03 am
Upgrades
Underweight
Equal Weight
Morgan Stanley
High
12.2%
4/29
05:09 am
Upgrades
Underweight
Equal-Weight
Morgan Stanley
High
12.2%
4/29
05:09 am
Upgrades
Underweight
Equal-Weight
Morgan Stanley
High
12.2%
4/12
10:08 am
Reiterates
Overweight
Overweight
Cantor Fitzgerald
Medium
-4.3%
4/26
04:33 pm
ptct
High
Form DEFA14A PTC THERAPEUTICS, INC.
4/26
04:31 pm
ptct
High
Form DEF 14A PTC THERAPEUTICS, INC. For: Jun 18
4/25
04:37 pm
ptct
High
Form 10-Q PTC THERAPEUTICS, INC. For: Mar 31
4/25
04:11 pm
ptct
High
Form 8-K PTC THERAPEUTICS, INC. For: Apr 25
4/22
05:20 pm
ptct
Low
Form 4 PTC THERAPEUTICS, INC. For: Apr 19 Filed by: Klein Matthew B.
Show more
Top News Gainers
2/6 Biogen Stock Rockets On Key Patent Win — Is It Time To Buy Shares? [Investor's Business Daily] 10.5%
3/4 PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $51.00 price target on the stock. 9.3%
10/29 PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 7.9%
5/8 PTC Therapeutics to Participate at Upcoming Investor Conferences 7.9%
3/18 Form 4 PTC THERAPEUTICS, INC. For: Mar 16 Filed by: SCHMERTZLER MICHAEL 6.2%
6/17 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.9%
3/18 Form SEC STAFF LETTER PTC THERAPEUTICS, INC. 5.7%
10/2 Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress 5.6%
3/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 5.5%
4/17 PTC Therapeutics Announces New Leadership Appointments 4.8%
Top News Decliners
3/16 PTC Therapeutics Announces Management Change -19.5%
3/11 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -11.4%
9/17 PTC Therapeutics Announces Proposed Public Offering of Common Stock -11.3%
4/29 PTC Therapeutics Q1 2020 Earnings Preview [Seeking Alpha] -9.4%
3/2 Form 8-K PTC THERAPEUTICS, INC. For: Mar 02 -5.8%
4/30 Q1/2020 3/31/2020 EPS -1.810 ZacksConsensus -1.080 ActVsEst (0.730) - Miss -5.7%
9/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was given a new $62.00 price target on by analysts at Citigroup Inc. They now have a "buy" rating on the stock. -4.7%
8/5 PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility -4.6%
1/13 PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference -4.2%
6/13 Form 8-K PTC THERAPEUTICS, INC. For: Jun 12 -4.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3